Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies

  title={Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies},
  author={Prashanth Rawla and Tagore Sunkara and Krishna Chaitanya Thandra and Vinaya Gaduputi},
  journal={Clinical Journal of Gastroenterology},
Hypertriglyceridemia (HTG) is an uncommon but well-established cause of acute pancreatitis (AP) comprising up to 7% of the cases. The clinical course of HTG-induced pancreatitis (HTGP) is highly similar to that of AP of other etiologies with HTG being the only distinguishing clinical feature. However, HTGP is often correlated with higher severity and elevated complication rate. At present, no approved treatment guideline for the management of HTGP is available, although different treatment… 

Hypertriglyceridemic Pancreatitis: Is Insulin Monotherapy A Feasible Therapeutic Option?

The use of insulin therapy for HTGP is illustrated as a feasible therapeutic choice and Randomized controlled trials are warranted to outline a generalized and efficient treatment for this serious disorder.

Hypertriglyceridemic Pancreatitis Treated with Insulin Therapy: A Comparative Review of 34 Cases

This review illustrates that the use of insulin therapy with close monitoring of blood glucose levels is safe and can be considered as an important component of management in patients with hypertriglyceridemia-related pancreatitis, especially in a clinical setting without the availability of plasmapheresis.

Treatment of Severe Hypertriglyceridemia-Induced Acute Pancreatitis with Subcutaneous Insulin: Case Report

A 50-year-old woman with a 3-year history of type 2 diabetes was admitted to the authors' hospital after experiencing upper abdominal pain for 1 day and diagnosed with severe acute HTGP, which was successfully managed with supportive care, subcutaneous insulin, and fenofibrate.

The role of plasma exchange in hypertriglyceridemia-induced acute pancreatitis

Although PE effectively reduced plasma triglyceride levels, there was no decrease in mortality or recurrences in patients with HTG-induced acute pancreatitis who underwent PE.

Hypertriglyceridemia with acute pancreatitis in a 14-year-old girl with diabetic ketoacidosis

It is recommended to consider AP in all DKA patients presenting with severe HTG to ensure early and proper management, and this is the first reported case of HTG-induced AP with DKA in a patient with MODY.

Hypertriglyceridemia induced acute pancreatitis managed with low dose intravenous Insulin.

  • Medicine
  • 2020
Although the lowest reported dose of Insulin was used, it was safe and effective to lower hypertriglyceridemia within two days and improves outcome of AP.

Hypertriglyceridemia induced acute pancreatitis: 4 years’ experience from a tertiary care institute and quick literature review

This retrospective case series includes a 4-year experience with HTG-AP at the authors' facility and a brief literature review, which indicates that the overall clinical outcomes are similar to other aetiologies.

Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity

Background The association of serum triglyceride (TG) levels with the severity of hypertriglyceridaemia-induced acute pancreatitis (HTG-AP) remains controversial. This study aimed to comprehensively



Issues in hypertriglyceridemic pancreatitis: an update.

Diet, lifestyle changes, and control of secondary factors are key to the treatment, and medications are useful adjuncts to the long-term management of TG levels.

Hypertriglyceride Induced Acute Pancreatitis

A case of hypertriglyceridemic pancreatitis managed with insulin, heparin and octreotide is presented with dramatic results; a logarithmic decrease in serum TGL magnitude and a significant reduction in the time to resolution as compared with previous reports of treatment with insulin andHeparin alone.

Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin

Administration of insulin is efficient when used to reduce triglyceride levels in patients with HT-induced AP and may be used safely and effectively in HT- induced AP therapy, compatible with the literature.

Hypertriglyceridemia-Induced Pancreatitis: Choice of Treatment

The case of a 44-year-old female with clinical acute pancreatitis secondary to hypertriglyceridemia who was successfully managed with the addition of intravenous insulin is reported.

Therapeutic plasma exchange for hypertriglyceridemia induced pancreatitis: A rapid and practical approach.

Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology?

Hypertriglyceridemia-Induced Pancreatitis: A Decade of Experience in a Community-Based Teaching Hospital.

A retrospective review of patients seen at a community-teaching hospital between 2005 and 2015 strengthens the evidence for using insulin (infusion or subcutaneous) with or without plasmapheresis in the treatment of hypertriglycerimia-induced pancreatitis.

Clinical features and treatment of hypertriglyceridemia‐induced acute pancreatitis during pregnancy: A retrospective study

Plasmapheresis may be safe and effectively administered for HTGP patients during pregnancy with SIRS or multiple organ dysfunction syndrome (MODS), J. Clin.

Hypertriglyceridemia-induced acute pancreatitis

There is no clear evidence as to which hypertriglyceridemia patients will develop acute pancreatitis and which will not, but Insulin, heparin, plasmapheresis and different antihyperlipidemic agents, as well as dietary modifications, are key features in the management of HTGP.

Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis

Reviewing the current literature, plasmapheresis appears to be a safe and useful therapeutic tool in patients suffering from SHTG and data suggests that the use of apheresis should be performed as early as possible in order to achieve best results.